SER100 in Isolated Systolic Hypertension

NCT01987284 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Isolated Systolic Hypertension

Interventions

DRUG: SER100
DRUG: Placebo

Sponsor

Serodus AS

Collaborators

[object Object]
[object Object]